Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk of Ocular Adverse Events with Taxane Based Chemotherapy

Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
doi: https://doi.org/10.1101/2022.02.15.22270863
Mohit Sodhi
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
2Faculty of Medicine, University of British Columbia, Vancouver, Canada
MSc, MD (candidate)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia N. Yeung
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Maberley
3Department of Ophthalmology, Faculty of Medicine, University of Ottawa, Ottawa, Canada
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick Mikelberg
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahyar Etminan
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
4Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada
PharmD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: etminanm{at}mail.ubc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: February 2022 to July 2025

AbstractFullPdf
Feb 2022395940
Mar 20222711324
Apr 2022152111
May 2022196121
Jun 2022126229
Jul 2022148110
Aug 202294410
Sep 2022135014
Oct 202292115
Nov 20227209
Dec 202275112
Jan 202367017
Feb 20236016
Mar 20237009
Apr 202389213
May 20235416
Jun 20234344
Jul 20235026
Aug 202350148
Sep 20234349
Oct 20234427
Nov 20233339
Dec 20235138
Jan 20242308
Feb 20243224
Mar 20243214
Apr 20243014
May 20243104
Jun 20244159
Jul 20243517
Aug 20244227
Sep 202446510
Oct 202436411
Nov 202426112
Dec 202433212
Jan 20251948
Feb 2025211510
Mar 2025431611
Apr 202546223
May 202547620
Jun 20253377
Jul 2025853
Back to top
PreviousNext
Posted February 17, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
medRxiv 2022.02.15.22270863; doi: https://doi.org/10.1101/2022.02.15.22270863
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
medRxiv 2022.02.15.22270863; doi: https://doi.org/10.1101/2022.02.15.22270863

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)